인쇄하기
취소

Drug makers increase cashable assets amid economic woes and unpredictable variables

Published: 2013-09-04 07:00:00
Updated: 2013-09-04 07:00:00
Influenced by persistent market uncertainty together with worsening business conditions, Korean pharmaceutical firms are choosing to hold more of their earnings in cashable assets as they find it harder to invest.

Cashable assets include cash, cash equivalents and other short-term financial products with a maturity of less than three months that can be immediately cashed with little cost.

...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.